nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—CYP3A4—Everolimus—kidney cancer	0.187	0.293	CbGbCtD
Clindamycin—CYP3A4—Temsirolimus—kidney cancer	0.126	0.198	CbGbCtD
Clindamycin—CYP3A4—Pazopanib—kidney cancer	0.0662	0.104	CbGbCtD
Clindamycin—CYP3A4—Erlotinib—kidney cancer	0.0473	0.0741	CbGbCtD
Clindamycin—CYP3A4—Paclitaxel—kidney cancer	0.0433	0.0678	CbGbCtD
Clindamycin—CYP3A4—Sorafenib—kidney cancer	0.0384	0.0603	CbGbCtD
Clindamycin—CYP3A4—Vinblastine—kidney cancer	0.0379	0.0595	CbGbCtD
Clindamycin—CYP3A4—Vincristine—kidney cancer	0.0373	0.0585	CbGbCtD
Clindamycin—CYP3A4—Sunitinib—kidney cancer	0.0311	0.0488	CbGbCtD
Clindamycin—CYP3A4—Doxorubicin—kidney cancer	0.0233	0.0366	CbGbCtD
Clindamycin—Oesophagitis—Doxorubicin—kidney cancer	0.000315	0.000868	CcSEcCtD
Clindamycin—Anaemia—Gemcitabine—kidney cancer	0.000314	0.000867	CcSEcCtD
Clindamycin—Neutropenia—Capecitabine—kidney cancer	0.000313	0.000865	CcSEcCtD
Clindamycin—Dysuria—Capecitabine—kidney cancer	0.000313	0.000865	CcSEcCtD
Clindamycin—Rash maculo-papular—Doxorubicin—kidney cancer	0.000313	0.000864	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000312	0.00086	CcSEcCtD
Clindamycin—Nausea—Pazopanib—kidney cancer	0.000311	0.000859	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00031	0.000856	CcSEcCtD
Clindamycin—Fatigue—Sorafenib—kidney cancer	0.00031	0.000855	CcSEcCtD
Clindamycin—Hypertension—Vincristine—kidney cancer	0.000309	0.000854	CcSEcCtD
Clindamycin—Erythema multiforme—Paclitaxel—kidney cancer	0.000309	0.000853	CcSEcCtD
Clindamycin—Dyspnoea—Sunitinib—kidney cancer	0.000308	0.00085	CcSEcCtD
Clindamycin—Pain—Sorafenib—kidney cancer	0.000307	0.000848	CcSEcCtD
Clindamycin—Constipation—Sorafenib—kidney cancer	0.000307	0.000848	CcSEcCtD
Clindamycin—Hypersensitivity—Vinblastine—kidney cancer	0.000306	0.000845	CcSEcCtD
Clindamycin—Photosensitivity reaction—Capecitabine—kidney cancer	0.000306	0.000844	CcSEcCtD
Clindamycin—Hypersensitivity—Everolimus—kidney cancer	0.000305	0.000841	CcSEcCtD
Clindamycin—Dyspepsia—Sunitinib—kidney cancer	0.000304	0.00084	CcSEcCtD
Clindamycin—Leukopenia—Gemcitabine—kidney cancer	0.000304	0.00084	CcSEcCtD
Clindamycin—Flushing—Paclitaxel—kidney cancer	0.000303	0.000837	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000298	0.000824	CcSEcCtD
Clindamycin—Asthenia—Vinblastine—kidney cancer	0.000298	0.000823	CcSEcCtD
Clindamycin—Fatigue—Sunitinib—kidney cancer	0.000298	0.000822	CcSEcCtD
Clindamycin—Asthenia—Everolimus—kidney cancer	0.000297	0.000819	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000296	0.000818	CcSEcCtD
Clindamycin—Pain—Sunitinib—kidney cancer	0.000296	0.000816	CcSEcCtD
Clindamycin—Constipation—Sunitinib—kidney cancer	0.000296	0.000816	CcSEcCtD
Clindamycin—Gastrointestinal pain—Sorafenib—kidney cancer	0.000294	0.000811	CcSEcCtD
Clindamycin—Hypertension—Gemcitabine—kidney cancer	0.000293	0.00081	CcSEcCtD
Clindamycin—Pruritus—Everolimus—kidney cancer	0.000293	0.000808	CcSEcCtD
Clindamycin—Anaphylactic shock—Vincristine—kidney cancer	0.000292	0.000807	CcSEcCtD
Clindamycin—Jaundice—Capecitabine—kidney cancer	0.000291	0.000804	CcSEcCtD
Clindamycin—Urinary tract infection—Capecitabine—kidney cancer	0.00029	0.000802	CcSEcCtD
Clindamycin—Thrombophlebitis—Doxorubicin—kidney cancer	0.000289	0.000797	CcSEcCtD
Clindamycin—Asthenia—Erlotinib—kidney cancer	0.000287	0.000791	CcSEcCtD
Clindamycin—Thrombocytopenia—Vincristine—kidney cancer	0.000286	0.00079	CcSEcCtD
Clindamycin—Discomfort—Gemcitabine—kidney cancer	0.000286	0.000789	CcSEcCtD
Clindamycin—Urticaria—Sorafenib—kidney cancer	0.000285	0.000788	CcSEcCtD
Clindamycin—Erythema—Paclitaxel—kidney cancer	0.000285	0.000785	CcSEcCtD
Clindamycin—Diarrhoea—Vinblastine—kidney cancer	0.000284	0.000784	CcSEcCtD
Clindamycin—Abdominal pain—Sorafenib—kidney cancer	0.000284	0.000784	CcSEcCtD
Clindamycin—Body temperature increased—Sorafenib—kidney cancer	0.000284	0.000784	CcSEcCtD
Clindamycin—Diarrhoea—Everolimus—kidney cancer	0.000283	0.000781	CcSEcCtD
Clindamycin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000283	0.00078	CcSEcCtD
Clindamycin—Pruritus—Erlotinib—kidney cancer	0.000283	0.00078	CcSEcCtD
Clindamycin—Fatigue—Dactinomycin—kidney cancer	0.000282	0.000779	CcSEcCtD
Clindamycin—Epistaxis—Capecitabine—kidney cancer	0.000282	0.000778	CcSEcCtD
Clindamycin—Flatulence—Paclitaxel—kidney cancer	0.00028	0.000774	CcSEcCtD
Clindamycin—Pain—Dactinomycin—kidney cancer	0.00028	0.000772	CcSEcCtD
Clindamycin—Agranulocytosis—Capecitabine—kidney cancer	0.000279	0.00077	CcSEcCtD
Clindamycin—Dysgeusia—Paclitaxel—kidney cancer	0.000279	0.000769	CcSEcCtD
Clindamycin—Anaphylactic shock—Gemcitabine—kidney cancer	0.000277	0.000765	CcSEcCtD
Clindamycin—Back pain—Paclitaxel—kidney cancer	0.000275	0.00076	CcSEcCtD
Clindamycin—Dizziness—Vinblastine—kidney cancer	0.000275	0.000758	CcSEcCtD
Clindamycin—Dizziness—Everolimus—kidney cancer	0.000274	0.000755	CcSEcCtD
Clindamycin—Muscle spasms—Paclitaxel—kidney cancer	0.000274	0.000755	CcSEcCtD
Clindamycin—Abdominal pain—Sunitinib—kidney cancer	0.000273	0.000754	CcSEcCtD
Clindamycin—Body temperature increased—Sunitinib—kidney cancer	0.000273	0.000754	CcSEcCtD
Clindamycin—Diarrhoea—Erlotinib—kidney cancer	0.000273	0.000754	CcSEcCtD
Clindamycin—Hypotension—Vincristine—kidney cancer	0.000273	0.000754	CcSEcCtD
Clindamycin—Thrombocytopenia—Gemcitabine—kidney cancer	0.000272	0.000749	CcSEcCtD
Clindamycin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000268	0.000738	CcSEcCtD
Clindamycin—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000265	0.000731	CcSEcCtD
Clindamycin—Hypersensitivity—Sorafenib—kidney cancer	0.000265	0.00073	CcSEcCtD
Clindamycin—Vomiting—Vinblastine—kidney cancer	0.000264	0.000729	CcSEcCtD
Clindamycin—Dizziness—Erlotinib—kidney cancer	0.000264	0.000729	CcSEcCtD
Clindamycin—Vomiting—Everolimus—kidney cancer	0.000263	0.000726	CcSEcCtD
Clindamycin—Anaemia—Paclitaxel—kidney cancer	0.000263	0.000726	CcSEcCtD
Clindamycin—Dermatitis bullous—Doxorubicin—kidney cancer	0.000262	0.000722	CcSEcCtD
Clindamycin—Rash—Everolimus—kidney cancer	0.000261	0.00072	CcSEcCtD
Clindamycin—Dermatitis—Everolimus—kidney cancer	0.000261	0.000719	CcSEcCtD
Clindamycin—Headache—Vinblastine—kidney cancer	0.00026	0.000718	CcSEcCtD
Clindamycin—Headache—Everolimus—kidney cancer	0.000259	0.000715	CcSEcCtD
Clindamycin—Hypotension—Gemcitabine—kidney cancer	0.000259	0.000715	CcSEcCtD
Clindamycin—Abdominal pain—Dactinomycin—kidney cancer	0.000259	0.000714	CcSEcCtD
Clindamycin—Body temperature increased—Dactinomycin—kidney cancer	0.000259	0.000714	CcSEcCtD
Clindamycin—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000258	0.000713	CcSEcCtD
Clindamycin—Asthenia—Sorafenib—kidney cancer	0.000258	0.000711	CcSEcCtD
Clindamycin—Vertigo—Paclitaxel—kidney cancer	0.000256	0.000706	CcSEcCtD
Clindamycin—Leukopenia—Paclitaxel—kidney cancer	0.000255	0.000703	CcSEcCtD
Clindamycin—Hypersensitivity—Sunitinib—kidney cancer	0.000255	0.000703	CcSEcCtD
Clindamycin—Pruritus—Sorafenib—kidney cancer	0.000254	0.000701	CcSEcCtD
Clindamycin—Vomiting—Erlotinib—kidney cancer	0.000254	0.000701	CcSEcCtD
Clindamycin—Erythema multiforme—Capecitabine—kidney cancer	0.000254	0.0007	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000252	0.000697	CcSEcCtD
Clindamycin—Fatigue—Vincristine—kidney cancer	0.000252	0.000696	CcSEcCtD
Clindamycin—Rash—Erlotinib—kidney cancer	0.000252	0.000695	CcSEcCtD
Clindamycin—Dermatitis—Erlotinib—kidney cancer	0.000252	0.000694	CcSEcCtD
Clindamycin—Headache—Erlotinib—kidney cancer	0.00025	0.00069	CcSEcCtD
Clindamycin—Pain—Vincristine—kidney cancer	0.00025	0.00069	CcSEcCtD
Clindamycin—Constipation—Vincristine—kidney cancer	0.00025	0.00069	CcSEcCtD
Clindamycin—Flushing—Capecitabine—kidney cancer	0.000249	0.000687	CcSEcCtD
Clindamycin—Asthenia—Sunitinib—kidney cancer	0.000248	0.000684	CcSEcCtD
Clindamycin—Dyspnoea—Gemcitabine—kidney cancer	0.000247	0.000682	CcSEcCtD
Clindamycin—Nausea—Vinblastine—kidney cancer	0.000247	0.000681	CcSEcCtD
Clindamycin—Nausea—Everolimus—kidney cancer	0.000246	0.000678	CcSEcCtD
Clindamycin—Diarrhoea—Sorafenib—kidney cancer	0.000246	0.000678	CcSEcCtD
Clindamycin—Hypertension—Paclitaxel—kidney cancer	0.000246	0.000678	CcSEcCtD
Clindamycin—Pruritus—Sunitinib—kidney cancer	0.000245	0.000675	CcSEcCtD
Clindamycin—Hypersensitivity—Dactinomycin—kidney cancer	0.000241	0.000665	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000239	0.000661	CcSEcCtD
Clindamycin—Discomfort—Paclitaxel—kidney cancer	0.000239	0.000661	CcSEcCtD
Clindamycin—Fatigue—Gemcitabine—kidney cancer	0.000239	0.00066	CcSEcCtD
Clindamycin—Gastrointestinal pain—Vincristine—kidney cancer	0.000239	0.00066	CcSEcCtD
Clindamycin—Cardiac arrest—Doxorubicin—kidney cancer	0.000238	0.000656	CcSEcCtD
Clindamycin—Dizziness—Sorafenib—kidney cancer	0.000238	0.000656	CcSEcCtD
Clindamycin—Pain—Gemcitabine—kidney cancer	0.000237	0.000655	CcSEcCtD
Clindamycin—Constipation—Gemcitabine—kidney cancer	0.000237	0.000655	CcSEcCtD
Clindamycin—Nausea—Erlotinib—kidney cancer	0.000237	0.000655	CcSEcCtD
Clindamycin—Diarrhoea—Sunitinib—kidney cancer	0.000237	0.000653	CcSEcCtD
Clindamycin—Asthenia—Dactinomycin—kidney cancer	0.000235	0.000648	CcSEcCtD
Clindamycin—Erythema—Capecitabine—kidney cancer	0.000234	0.000644	CcSEcCtD
Clindamycin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000232	0.000641	CcSEcCtD
Clindamycin—Body temperature increased—Vincristine—kidney cancer	0.000231	0.000638	CcSEcCtD
Clindamycin—Abdominal pain—Vincristine—kidney cancer	0.000231	0.000638	CcSEcCtD
Clindamycin—Flatulence—Capecitabine—kidney cancer	0.00023	0.000635	CcSEcCtD
Clindamycin—Dry skin—Doxorubicin—kidney cancer	0.000229	0.000632	CcSEcCtD
Clindamycin—Dysgeusia—Capecitabine—kidney cancer	0.000229	0.000631	CcSEcCtD
Clindamycin—Dizziness—Sunitinib—kidney cancer	0.000229	0.000631	CcSEcCtD
Clindamycin—Vomiting—Sorafenib—kidney cancer	0.000228	0.00063	CcSEcCtD
Clindamycin—Abdominal pain upper—Doxorubicin—kidney cancer	0.000228	0.00063	CcSEcCtD
Clindamycin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000227	0.000627	CcSEcCtD
Clindamycin—Rash—Sorafenib—kidney cancer	0.000227	0.000625	CcSEcCtD
Clindamycin—Dermatitis—Sorafenib—kidney cancer	0.000226	0.000625	CcSEcCtD
Clindamycin—Back pain—Capecitabine—kidney cancer	0.000226	0.000623	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000225	0.000621	CcSEcCtD
Clindamycin—Headache—Sorafenib—kidney cancer	0.000225	0.000621	CcSEcCtD
Clindamycin—Muscle spasms—Capecitabine—kidney cancer	0.000225	0.00062	CcSEcCtD
Clindamycin—Diarrhoea—Dactinomycin—kidney cancer	0.000224	0.000618	CcSEcCtD
Clindamycin—Vomiting—Sunitinib—kidney cancer	0.00022	0.000607	CcSEcCtD
Clindamycin—Body temperature increased—Gemcitabine—kidney cancer	0.000219	0.000605	CcSEcCtD
Clindamycin—Rash—Sunitinib—kidney cancer	0.000218	0.000601	CcSEcCtD
Clindamycin—Dermatitis—Sunitinib—kidney cancer	0.000218	0.000601	CcSEcCtD
Clindamycin—Abdominal distension—Doxorubicin—kidney cancer	0.000218	0.0006	CcSEcCtD
Clindamycin—Hypotension—Paclitaxel—kidney cancer	0.000217	0.000599	CcSEcCtD
Clindamycin—Headache—Sunitinib—kidney cancer	0.000217	0.000598	CcSEcCtD
Clindamycin—Anaemia—Capecitabine—kidney cancer	0.000216	0.000596	CcSEcCtD
Clindamycin—Hypersensitivity—Vincristine—kidney cancer	0.000215	0.000594	CcSEcCtD
Clindamycin—Eosinophilia—Doxorubicin—kidney cancer	0.000214	0.00059	CcSEcCtD
Clindamycin—Nausea—Sorafenib—kidney cancer	0.000213	0.000589	CcSEcCtD
Clindamycin—Vertigo—Capecitabine—kidney cancer	0.00021	0.000579	CcSEcCtD
Clindamycin—Asthenia—Vincristine—kidney cancer	0.00021	0.000579	CcSEcCtD
Clindamycin—Leukopenia—Capecitabine—kidney cancer	0.000209	0.000577	CcSEcCtD
Clindamycin—Vomiting—Dactinomycin—kidney cancer	0.000208	0.000574	CcSEcCtD
Clindamycin—Dyspnoea—Paclitaxel—kidney cancer	0.000207	0.000571	CcSEcCtD
Clindamycin—Rash—Dactinomycin—kidney cancer	0.000206	0.000569	CcSEcCtD
Clindamycin—Nausea—Sunitinib—kidney cancer	0.000205	0.000567	CcSEcCtD
Clindamycin—Dyspepsia—Paclitaxel—kidney cancer	0.000204	0.000564	CcSEcCtD
Clindamycin—Dysuria—Doxorubicin—kidney cancer	0.000202	0.000557	CcSEcCtD
Clindamycin—Neutropenia—Doxorubicin—kidney cancer	0.000202	0.000557	CcSEcCtD
Clindamycin—Hypertension—Capecitabine—kidney cancer	0.000202	0.000556	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000201	0.000554	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000201	0.000553	CcSEcCtD
Clindamycin—Fatigue—Paclitaxel—kidney cancer	0.0002	0.000553	CcSEcCtD
Clindamycin—Diarrhoea—Vincristine—kidney cancer	0.0002	0.000552	CcSEcCtD
Clindamycin—Asthenia—Gemcitabine—kidney cancer	0.000199	0.000549	CcSEcCtD
Clindamycin—Constipation—Paclitaxel—kidney cancer	0.000199	0.000548	CcSEcCtD
Clindamycin—Pain—Paclitaxel—kidney cancer	0.000199	0.000548	CcSEcCtD
Clindamycin—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000197	0.000544	CcSEcCtD
Clindamycin—Discomfort—Capecitabine—kidney cancer	0.000196	0.000542	CcSEcCtD
Clindamycin—Pruritus—Gemcitabine—kidney cancer	0.000196	0.000542	CcSEcCtD
Clindamycin—Nausea—Dactinomycin—kidney cancer	0.000194	0.000536	CcSEcCtD
Clindamycin—Dizziness—Vincristine—kidney cancer	0.000193	0.000534	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000191	0.000527	CcSEcCtD
Clindamycin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00019	0.000524	CcSEcCtD
Clindamycin—Diarrhoea—Gemcitabine—kidney cancer	0.00019	0.000524	CcSEcCtD
Clindamycin—Jaundice—Doxorubicin—kidney cancer	0.000188	0.000518	CcSEcCtD
Clindamycin—Urinary tract infection—Doxorubicin—kidney cancer	0.000187	0.000517	CcSEcCtD
Clindamycin—Thrombocytopenia—Capecitabine—kidney cancer	0.000187	0.000515	CcSEcCtD
Clindamycin—Vomiting—Vincristine—kidney cancer	0.000186	0.000513	CcSEcCtD
Clindamycin—Urticaria—Paclitaxel—kidney cancer	0.000185	0.000509	CcSEcCtD
Clindamycin—Rash—Vincristine—kidney cancer	0.000184	0.000509	CcSEcCtD
Clindamycin—Dermatitis—Vincristine—kidney cancer	0.000184	0.000508	CcSEcCtD
Clindamycin—Abdominal pain—Paclitaxel—kidney cancer	0.000184	0.000507	CcSEcCtD
Clindamycin—Body temperature increased—Paclitaxel—kidney cancer	0.000184	0.000507	CcSEcCtD
Clindamycin—Headache—Vincristine—kidney cancer	0.000183	0.000505	CcSEcCtD
Clindamycin—Epistaxis—Doxorubicin—kidney cancer	0.000182	0.000501	CcSEcCtD
Clindamycin—Agranulocytosis—Doxorubicin—kidney cancer	0.00018	0.000496	CcSEcCtD
Clindamycin—Hypotension—Capecitabine—kidney cancer	0.000178	0.000491	CcSEcCtD
Clindamycin—Vomiting—Gemcitabine—kidney cancer	0.000176	0.000487	CcSEcCtD
Clindamycin—Rash—Gemcitabine—kidney cancer	0.000175	0.000483	CcSEcCtD
Clindamycin—Dermatitis—Gemcitabine—kidney cancer	0.000175	0.000482	CcSEcCtD
Clindamycin—Headache—Gemcitabine—kidney cancer	0.000174	0.00048	CcSEcCtD
Clindamycin—Nausea—Vincristine—kidney cancer	0.000174	0.000479	CcSEcCtD
Clindamycin—Hypersensitivity—Paclitaxel—kidney cancer	0.000171	0.000472	CcSEcCtD
Clindamycin—Dyspnoea—Capecitabine—kidney cancer	0.00017	0.000469	CcSEcCtD
Clindamycin—Dyspepsia—Capecitabine—kidney cancer	0.000168	0.000463	CcSEcCtD
Clindamycin—Asthenia—Paclitaxel—kidney cancer	0.000167	0.00046	CcSEcCtD
Clindamycin—Nausea—Gemcitabine—kidney cancer	0.000165	0.000455	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000165	0.000454	CcSEcCtD
Clindamycin—Fatigue—Capecitabine—kidney cancer	0.000164	0.000453	CcSEcCtD
Clindamycin—Pruritus—Paclitaxel—kidney cancer	0.000164	0.000453	CcSEcCtD
Clindamycin—Erythema multiforme—Doxorubicin—kidney cancer	0.000164	0.000451	CcSEcCtD
Clindamycin—Pain—Capecitabine—kidney cancer	0.000163	0.00045	CcSEcCtD
Clindamycin—Constipation—Capecitabine—kidney cancer	0.000163	0.00045	CcSEcCtD
Clindamycin—Flushing—Doxorubicin—kidney cancer	0.00016	0.000443	CcSEcCtD
Clindamycin—Diarrhoea—Paclitaxel—kidney cancer	0.000159	0.000438	CcSEcCtD
Clindamycin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000156	0.00043	CcSEcCtD
Clindamycin—Dizziness—Paclitaxel—kidney cancer	0.000154	0.000424	CcSEcCtD
Clindamycin—Urticaria—Capecitabine—kidney cancer	0.000151	0.000418	CcSEcCtD
Clindamycin—Body temperature increased—Capecitabine—kidney cancer	0.000151	0.000416	CcSEcCtD
Clindamycin—Abdominal pain—Capecitabine—kidney cancer	0.000151	0.000416	CcSEcCtD
Clindamycin—Erythema—Doxorubicin—kidney cancer	0.000151	0.000415	CcSEcCtD
Clindamycin—Flatulence—Doxorubicin—kidney cancer	0.000148	0.000409	CcSEcCtD
Clindamycin—Vomiting—Paclitaxel—kidney cancer	0.000148	0.000407	CcSEcCtD
Clindamycin—Dysgeusia—Doxorubicin—kidney cancer	0.000147	0.000407	CcSEcCtD
Clindamycin—Rash—Paclitaxel—kidney cancer	0.000146	0.000404	CcSEcCtD
Clindamycin—Dermatitis—Paclitaxel—kidney cancer	0.000146	0.000404	CcSEcCtD
Clindamycin—Back pain—Doxorubicin—kidney cancer	0.000146	0.000402	CcSEcCtD
Clindamycin—Headache—Paclitaxel—kidney cancer	0.000146	0.000401	CcSEcCtD
Clindamycin—Muscle spasms—Doxorubicin—kidney cancer	0.000145	0.000399	CcSEcCtD
Clindamycin—Hypersensitivity—Capecitabine—kidney cancer	0.00014	0.000387	CcSEcCtD
Clindamycin—Anaemia—Doxorubicin—kidney cancer	0.000139	0.000384	CcSEcCtD
Clindamycin—Nausea—Paclitaxel—kidney cancer	0.000138	0.000381	CcSEcCtD
Clindamycin—Asthenia—Capecitabine—kidney cancer	0.000137	0.000377	CcSEcCtD
Clindamycin—Vertigo—Doxorubicin—kidney cancer	0.000135	0.000373	CcSEcCtD
Clindamycin—Pruritus—Capecitabine—kidney cancer	0.000135	0.000372	CcSEcCtD
Clindamycin—Leukopenia—Doxorubicin—kidney cancer	0.000135	0.000372	CcSEcCtD
Clindamycin—Diarrhoea—Capecitabine—kidney cancer	0.00013	0.00036	CcSEcCtD
Clindamycin—Hypertension—Doxorubicin—kidney cancer	0.00013	0.000359	CcSEcCtD
Clindamycin—Discomfort—Doxorubicin—kidney cancer	0.000127	0.000349	CcSEcCtD
Clindamycin—Dizziness—Capecitabine—kidney cancer	0.000126	0.000348	CcSEcCtD
Clindamycin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000123	0.000339	CcSEcCtD
Clindamycin—Vomiting—Capecitabine—kidney cancer	0.000121	0.000334	CcSEcCtD
Clindamycin—Thrombocytopenia—Doxorubicin—kidney cancer	0.00012	0.000332	CcSEcCtD
Clindamycin—Rash—Capecitabine—kidney cancer	0.00012	0.000332	CcSEcCtD
Clindamycin—Dermatitis—Capecitabine—kidney cancer	0.00012	0.000331	CcSEcCtD
Clindamycin—Headache—Capecitabine—kidney cancer	0.000119	0.000329	CcSEcCtD
Clindamycin—Hypotension—Doxorubicin—kidney cancer	0.000115	0.000317	CcSEcCtD
Clindamycin—Nausea—Capecitabine—kidney cancer	0.000113	0.000312	CcSEcCtD
Clindamycin—Dyspnoea—Doxorubicin—kidney cancer	0.00011	0.000302	CcSEcCtD
Clindamycin—Dyspepsia—Doxorubicin—kidney cancer	0.000108	0.000298	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000106	0.000293	CcSEcCtD
Clindamycin—Fatigue—Doxorubicin—kidney cancer	0.000106	0.000292	CcSEcCtD
Clindamycin—Constipation—Doxorubicin—kidney cancer	0.000105	0.00029	CcSEcCtD
Clindamycin—Pain—Doxorubicin—kidney cancer	0.000105	0.00029	CcSEcCtD
Clindamycin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.0001	0.000277	CcSEcCtD
Clindamycin—Urticaria—Doxorubicin—kidney cancer	9.76e-05	0.000269	CcSEcCtD
Clindamycin—Abdominal pain—Doxorubicin—kidney cancer	9.71e-05	0.000268	CcSEcCtD
Clindamycin—Body temperature increased—Doxorubicin—kidney cancer	9.71e-05	0.000268	CcSEcCtD
Clindamycin—Hypersensitivity—Doxorubicin—kidney cancer	9.05e-05	0.00025	CcSEcCtD
Clindamycin—Asthenia—Doxorubicin—kidney cancer	8.82e-05	0.000243	CcSEcCtD
Clindamycin—Pruritus—Doxorubicin—kidney cancer	8.69e-05	0.00024	CcSEcCtD
Clindamycin—Diarrhoea—Doxorubicin—kidney cancer	8.41e-05	0.000232	CcSEcCtD
Clindamycin—Dizziness—Doxorubicin—kidney cancer	8.12e-05	0.000224	CcSEcCtD
Clindamycin—Vomiting—Doxorubicin—kidney cancer	7.81e-05	0.000216	CcSEcCtD
Clindamycin—Rash—Doxorubicin—kidney cancer	7.75e-05	0.000214	CcSEcCtD
Clindamycin—Dermatitis—Doxorubicin—kidney cancer	7.74e-05	0.000214	CcSEcCtD
Clindamycin—Headache—Doxorubicin—kidney cancer	7.7e-05	0.000212	CcSEcCtD
Clindamycin—Nausea—Doxorubicin—kidney cancer	7.3e-05	0.000201	CcSEcCtD
